As a biologics CDMO focused on developing and manufacturing recombinant protein products using mammalian cell culture ...

We assign Siegfried a Medium Morningstar Uncertainty Rating. Its business is relatively stable, with high switching costs and good visibility due to long-term customer contracts. However, small ...

In January, the U.S. Food and Drug Administration (FDA) issued its first guidance on the use of artificial intelligence (AI) ...

New service ensures rapid delivery of small volume clinical trial materials, solving a critical bottleneck in drug ...

Intelligent Omics' Dr Rob Grundy discusses how combining AI with big data can lead to better drug discovery processes and that partnerships can help more organisations leverage cutting-edge tools.

Integrating genomics and AI is key to increasing the probability of success and accelerating the delivery of treatments to ...

Cell line development plays a pivotal role in the manufacturing of therapeutic proteins, vaccines and other biologics.

With its GDP achieving a five percent growth year on year in 2024, China made great strides in its high-quality development, with trade and investment playing a crucial role in it. China is now a ...

In addition to supporting NurExone's internal drug development efforts, Exo-Top will be positioned to supply high-quality exosomes to other pharmaceutical ... greater control over its exosome ...

The Federal Medical Centre (FMC) Jalingo has reaffirmed its commitment to providing quality healthcare and making drugs available in the hospital for people accessing the facility. A senior staff ...

When he started his laboratory in 2013 at Florida State University, he began the process of developing ... could accelerate drug development timelines and enhance the quality of biotherapeutics ...

marking a transformative step in how Conduit would develop and deliver drug development. By leveraging AI, the Company is seeking to streamline drug repurposing, accelerate drug discovery ...